CLINICAL_TRIALS
trial_result
· 2021-06-10
Clinical Trial Update: Addressing Post Cessation Weight Gain [Phase 2, Phase 3]
Summary
A terminated Phase 2/3 clinical trial addressing post-cessation weight gain associated with smoking cessation programs.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Mayo Clinic | Conditions: Obesity, Smoking Cessation | Phase 2, Phase 3 | Status: TERMINATED | Results posted: 2021-06-10